Skip to main content

Advertisement

Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment

The original article was published in BMC Urology 2016 16:63

Erratum

After publication of this work [1] it was noticed that there was a typographical error in the Conclusions. The letter ‘a’ in ‘asymtoptomatic’ should have been removed in the concluding statement as it is inconsistent with the Results and Discussion. The statement in the Conclusions should read: ‘Patients who were symptomatic placed significantly more importance on delaying an SSE when expressing medication preferences.’

The original article was corrected. The publisher apologises for this error.

Reference

  1. 1.

    Uemura H, Matsubara N, Kimura G, Yamaguchi A, Ledesma DA, DiBonaventura M, et al. Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. BMC Urol. 2016;16:63.

Download references

Author information

Correspondence to Yasuko Aitoku.

Additional information

The online version of the original article can be found under doi:10.1186/s12894-016-0182-2.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark